S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Head and Neck Cancer|Lung Cancer|Prostate Cancer|Unspecified Adult Solid Tumor, Protocol Specific
Interventions: DRUG: docetaxel|DRUG: vandetanib|GENETIC: proteomic profiling|OTHER: laboratory biomarker analysis|OTHER: pharmacological study
Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)